Find and Pitch Jounalists, Get Your Story Covered

	Profile	Recent Articles on Subject
1	Frank Vinluan MedCity News Medical innovation tracker. MedCity, USA medicalinnovation	FDA Nod Paves Way for AstraZeneca Drug to Become New Standard of Care in Rare Blood Cancer - 14 days ago Astellas Pharma Lands a First-in-Class Drug Approval in Rare Gastrointestinal Cancer - 3 months ago
2	Kennedy Ferruggia, Assistant Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	Avutometinib Plus Defactinib Moves One Step Closer to Approval for Treatment of Ovarian Cancer - 25 days ago Antibody Drug Conjugate Targeting CLDN1 Receives FDA Fast Track Designation - 2 months ago CHMP Recommends Lazertinib With Amivantamab to Treat EGFR-Mutated Advanced NSCLC - 2 months ago Zaltenibart Receives FDA Rare Pediatric Disease Designation for C3 Glomerulopathy - 3 months ago Jazz Pharmaceuticals Submits Biologics License Application for Zanidatamab to Treat Biliary Tract Cancer - 10 months ago
3	John Pinching PharmaTimes Next-gen biopharma company. La Jolla, California biopharmadrugsdevices	Amgen’s lung cancer treatment gets conditional approval - 26 days ago MHRA grants approval for bladder cancer drug erdafitinib - 3 months ago
4	Greg Laub MedPage Today Director of Video at MedPage Today. Screenwriter, previous managing editor. videographyscreenwritingediting	Testing Elacestrant With Other Targeted Drugs for Metastatic Breast Cancer - about 1 month ago TIL Therapy May Offer Novel Approach for Metastatic Lung Cancer - 7 months ago Pirtobrutinib Shows Potential in Heavily Pretreated Follicular Lymphoma - about 1 year ago Novel Doublet Highly Effective in Low-Grade Serous Ovarian Cancer - about 1 year ago Ubamatamab Shows Some Activity in Recurrent Ovarian Cancer - about 1 year ago New Data on TYK2 Inhibitors for Psoriasis, Psoriatic Arthritis - about 1 year ago Anti-TIGIT Drug Fails to Lift Response Rates in Cervical Cancer Trial - about 1 year ago
5	Mike Bassett MedPage Today Explains healthcare complexities. Not endorsements. New York, New York Healthcare journalism	New First-Line Option for Advanced ALK-Positive Lung Cancer - about 1 month ago FDA Approves Zanidatamab for Biliary Tract Cancer - 2 months ago Antibody Drug-Conjugate Shows Promising Activity in Extensive-Stage SCLC - 5 months ago Targeted First-Line Combo Approved for EGFR-Mutated Lung Cancer - 5 months ago Osimertinib Shows Activity in NSCLC With Uncommon EGFR Mutations - about 1 year ago Bispecific Antibody Shows Clinical Activity in Recurrent Ovarian Cancer - about 1 year ago RET Inhibitor Posts Frontline Wins in Medullary Thyroid Cancer, NSCLC - over 1 year ago
6	Ian Ingram MedPage Today Deputy Managing Editor. MedPage Today. New York, New York medical journalismediting	Novel BTK Inhibitor Succeeds in Heavily Pretreated Immune Thrombocytopenia - about 2 months ago Brigatinib Makes Its Case for ALK-Positive ALCL in Small Study - 8 months ago FDA Approves New Frontline Regimen for Aggressive ALL - 11 months ago FDA OKs Amivantamab as First-Line Lung Cancer Treatment - 11 months ago JAK1 Inhibitor Shows 'Remarkable' Activity in T-Cell Lymphoma - about 1 year ago Menin Inhibitor Yields 63% ORR in Heavily Pretreated Acute Leukemia - about 1 year ago Non-Covalent BTK Inhibitor Approved for CLL - about 1 year ago Lymphoma Drug Copanlisib to Be Pulled From U.S. Market - about 1 year ago New Options Challenge Standard Treatments in EGFR-Mutant NSCLC - over 1 year ago Randomized Trial Backs HIF-2a Inhibition in Advanced RCC - over 1 year ago
7	Kristen Monaco MedPage Today	Complement Inhibitor Shows Promise for Rare Kidney Disorder - 3 months ago Interim ALIGN Data: Atrasentan Cuts Proteinuria in IgA Nephropathy - 3 months ago Alternative Pathway Inhibition Makes Good in IgA Nephropathy - 3 months ago
8	Ashley Gallagher, Associate Editor Pharmacy Times One of Cabra girls on GoggleboxIRL. Dublin City, Ireland televisionentertainment	FDA Accepts NDA and Priority Review Application for Vimseltinib in Tenosynovial Giant Cell Tumors - 5 months ago FDA Approves Amivantamab-Vmjw and Lazertinib for First-Line Treatment of NSCLC - 5 months ago FDA Grants Priority Review for Asciminib for Chronic Myeloid Leukemia - 6 months ago FDA Grants Fast Track Designation to Potential Treatment for Clear Cell Renal Cell Carcinoma - 7 months ago FDA Accepts Supplemental New Drug Application for Adagrasib for Colorectal Cancer - 11 months ago FDA Grants Orphan Drug Designation to Tigilanol Tiglate for Soft Tissue Sarcoma - 12 months ago FDA Approves Capivasertib With Fulvestrant for PIK3CA/ALT1/PTEN Alterations Breast Cancer - about 1 year ago FDA Approves Repotrectinib for Treatment of ROS1-Positive NSCLC - about 1 year ago TAK-279 Demonstrates Improvements in ACR 20 Response for Psoriatic Arthritis - about 1 year ago FDA Grants Priority Review to New Drug Application for Belzutifan for Advanced Renal Cell Carcinoma - over 1 year ago
9	Alana Hippensteele, Managing Editor Pharmacy Times #pharmacy news, insights. CE provider. Cranbury, New Jersey pharmacyhealthcarejournalism	FDA Approves Axatilimab-csfr for cGVHD - 6 months ago
10	Judy George MedPage Today Medical reporter, writer. Medical reportingartsliterature	ALS Therapy to Be Pulled From the Market, Drugmaker Says - 10 months ago

Journalists covering alectinib